Rödel F - Search Results

1

Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines.

Michaelis M, Voges Y, Rothweiler F, Weipert F, Zia-Ahmad A, Cinatl J, von Deimling A, Westermann F, Rödel F, Wass MN, Cinatl J Jr. Michaelis M, et al. Among authors: rodel f. Cancers (Basel). 2020 Mar 2;12(3):577. doi: 10.3390/cancers12030577. Cancers (Basel). 2020. PMID: 32131402 Free PMC article.

2

Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells.

Michaelis M, Rothweiler F, Barth S, Cinatl J, van Rikxoort M, Löschmann N, Voges Y, Breitling R, von Deimling A, Rödel F, Weber K, Fehse B, Mack E, Stiewe T, Doerr HW, Speidel D, Cinatl J Jr. Michaelis M, et al. Among authors: rodel f. Cell Death Dis. 2011 Dec 15;2(12):e243. doi: 10.1038/cddis.2011.129. Cell Death Dis. 2011. PMID: 22170099 Free PMC article.

3

Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents.

Michaelis M, Rothweiler F, Agha B, Barth S, Voges Y, Löschmann N, von Deimling A, Breitling R, Doerr HW, Rödel F, Speidel D, Cinatl J Jr. Michaelis M, et al. Among authors: rodel f. Cell Death Dis. 2012 Apr 5;3(4):e294. doi: 10.1038/cddis.2012.35. Cell Death Dis. 2012. PMID: 22476102 Free PMC article.

4

Drug-Resistant Urothelial Cancer Cell Lines Display Diverse Sensitivity Profiles to Potential Second-Line Therapeutics.

Vallo S, Michaelis M, Rothweiler F, Bartsch G, Gust KM, Limbart DM, Rödel F, Wezel F, Haferkamp A, Cinatl J Jr. Vallo S, et al. Among authors: rodel f. Transl Oncol. 2015 Jun;8(3):210-6. doi: 10.1016/j.tranon.2015.04.002. Transl Oncol. 2015. PMID: 26055179 Free PMC article.

5

Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistance.

Voges Y, Michaelis M, Rothweiler F, Schaller T, Schneider C, Politt K, Mernberger M, Nist A, Stiewe T, Wass MN, Rödel F, Cinatl J. Voges Y, et al. Among authors: rodel f. Cell Death Dis. 2016 Oct 13;7(10):e2410. doi: 10.1038/cddis.2016.257. Cell Death Dis. 2016. PMID: 27735941 Free PMC article.

6

Ionizing Radiation Induces Morphological Changes and Immunological Modulation of Jurkat Cells.

Voos P, Fuck S, Weipert F, Babel L, Tandl D, Meckel T, Hehlgans S, Fournier C, Moroni A, Rödel F, Thiel G. Voos P, et al. Among authors: rodel f. Front Immunol. 2018 Apr 30;9:922. doi: 10.3389/fimmu.2018.00922. eCollection 2018. Front Immunol. 2018. PMID: 29760710 Free PMC article.

7

YM155-Adapted Cancer Cell Lines Reveal Drug-Induced Heterogeneity and Enable the Identification of Biomarker Candidates for the Acquired Resistance Setting.

Michaelis M, Wass MN, Reddin I, Voges Y, Rothweiler F, Hehlgans S, Cinatl J, Mernberger M, Nist A, Stiewe T, Rödel F, Cinatl J Jr. Michaelis M, et al. Among authors: rodel f. Cancers (Basel). 2020 Apr 26;12(5):1080. doi: 10.3390/cancers12051080. Cancers (Basel). 2020. PMID: 32357518 Free PMC article.

8

Tumor Suppressor Protein p53 and Inhibitor of Apoptosis Proteins in Colorectal Cancer-A Promising Signaling Network for Therapeutic Interventions.

Güllülü Ö, Hehlgans S, Rödel C, Fokas E, Rödel F. Güllülü Ö, et al. Among authors: rodel c, rodel f. Cancers (Basel). 2021 Feb 4;13(4):624. doi: 10.3390/cancers13040624. Cancers (Basel). 2021. PMID: 33557398 Free PMC article. Review.

9

Arsenic Trioxide and (-)-Gossypol Synergistically Target Glioma Stem-Like Cells via Inhibition of Hedgehog and Notch Signaling.

Linder B, Wehle A, Hehlgans S, Bonn F, Dikic I, Rödel F, Seifert V, Kögel D. Linder B, et al. Among authors: rodel f. Cancers (Basel). 2019 Mar 12;11(3):350. doi: 10.3390/cancers11030350. Cancers (Basel). 2019. PMID: 30871073 Free PMC article.

10

NMDA Receptor-Mediated Signaling Pathways Enhance Radiation Resistance, Survival and Migration in Glioblastoma Cells-A Potential Target for Adjuvant Radiotherapy.

Müller-Längle A, Lutz H, Hehlgans S, Rödel F, Rau K, Laube B. Müller-Längle A, et al. Among authors: rodel f. Cancers (Basel). 2019 Apr 9;11(4):503. doi: 10.3390/cancers11040503. Cancers (Basel). 2019. PMID: 30970642 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page